LT - Migalastatas, skirtas naudoti taikant Fabri ligos gydymą pacientams, turintiems GLA geno mutaciją
EN - MIGALASTAT FOR USE IN TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENE
Legal status
Patent in force
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/445 |
(2006.01) |
|
|
A61P 3/00 |
(2006.01) |
European patent
| (11) |
Number of the document |
3984538 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
21197291.4 |
|
Date of filing the European patent application |
2020-08-07 |
| (97) |
Date of publication of the European application |
2022-04-20 |
| (45) |
Date of publication and mention of the grant of the patent |
2025-11-05
|
| (46) |
Date of publication of the claims translation |
2026-02-25
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
201962883756 P |
2019-08-07
|
US |
|
202062986297 P |
2020-03-06
|
US |
Inventors
| (72) |
BENJAMIN, Elfrida , US
WU, Xiaoyang , US
|
Grantee
| (73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Migalastatas, skirtas naudoti taikant Fabri ligos gydymą pacientams, turintiems GLA geno mutaciją |
| |
MIGALASTAT FOR USE IN TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENE |
